Herding: a new phenomenon affecting medical decision-making in multiple sclerosis care? Lessons learned from DIScUTIR MS

被引:11
|
作者
Saposnik, Gustavo [1 ,2 ,3 ]
Maurino, Jorge [4 ]
Sempere, Angel P. [5 ]
Ruff, Christian C. [2 ]
Tobler, Philippe N. [2 ]
机构
[1] Univ Toronto, St Michaels Hosp, Dept Med, Div Neurol, 55 Queen St East, Toronto, ON M5C 1R6, Canada
[2] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland
[3] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada
[4] Roche Farma, Dept Med, Neurosci Area, Madrid, Spain
[5] Hosp Gen Univ Alicante, Dept Neurol, Alicante, Spain
来源
基金
瑞士国家科学基金会;
关键词
multiple sclerosis; herding; disease-modifying therapy; neuroeconomics; decision-making; risk aversion; SOCIAL-INFLUENCE; INTERFERON-BETA; MANAGEMENT; RISK; MRI;
D O I
10.2147/PPA.S124192
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Herding is a phenomenon by which individuals follow the behavior of others rather than deciding independently on the basis of their own private information. A herding-like phenomenon can occur in multiple sclerosis (MS) when a neurologist follows a therapeutic recommendation by a colleague even though it is not supported by best practice clinical guidelines. Limited information is currently available on the role of herding in medical care. The objective of this study was to determine the prevalence (and its associated factors) of herding in the management of MS. Methods: We conducted a study among neurologists with expertise in MS care throughout Spain. Participants answered questions regarding the management of 20 case scenarios commonly encountered in clinical practice and completed 3 surveys and 4 experimental paradigms based on behavioral economics. The herding experiment consisted of a case scenario of a 40-year-old woman who has been stable for 3 years on subcutaneous interferon and developed a self-limited neurological event. There were no new magnetic resonance imaging (MRI) lesions. Her neurological examination and disability scores were unchanged. She was advised by an MS neurologist to switch from interferon to fingolimod against best practice guidelines. Multivariable logistic regression analysis was conducted to evaluate factors associated with herding. Results: Out of 161 neurologists who were invited to participate, 96 completed the study (response rate: 60%). Herding was present in 75 (78.1%), having a similar prevalence in MS experts and general neurologists (68.8% vs 82.8%; P=0.12). In multivariate analyses, the number of MS patients seen per week was positively associated with herding (odds ratio [OR] 1.08, 95% CI 1.01-1.14). Conversely, physician's age, gender, years of practice, setting of practice, or risk preferences were not associated with herding. Conclusion: Herding was a common phenomenon affecting nearly 8 out of 10 neurologists caring for MS patients. Herding may affect medical decisions and lead to poorer outcomes in the management of MS.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [41] Lessons learned from a new mini clinical skills assessment for medical students in the primary care clerkship
    Green, MM
    Butter, J
    Martin, GJ
    Makoul, G
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 : 91 - 91
  • [42] Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)
    Mowry, Ellen M.
    Bermel, Robert A.
    Williams, James R.
    Benzinger, Tammie L. S.
    de Moor, Carl
    Fisher, Elizabeth
    Hersh, Carrie M.
    Hyland, Megan H.
    Izbudak, Izlem
    Jones, Stephen E.
    Kieseier, Bernd C.
    Kitzler, Hagen H.
    Krupp, Lauren
    Lui, Yvonne W.
    Montalban, Xavier
    Naismith, Robert T.
    Nicholas, Jacqueline A.
    Pellegrini, Fabio
    Rovira, Alex
    Schulze, Maximilian
    Tackenberg, Bjoern
    Tintore, Mar
    Tivarus, Madalina E.
    Ziemssen, Tjalf
    Rudick, Richard A.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [43] Critical thinking about adverse drug effects: Lessons from the psychology of risk and medical decision-making for clinical psychopharmacology
    Nierenberg, Andrew A.
    Smoller, Jordan W.
    Eidelman, Polina
    Wu, Yelena P.
    Tilley, Claire A.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2008, 77 (04) : 201 - 208
  • [44] How Lung Cancer Patients Perceive their Treating Doctors and Engage in medical decision-making: Lessons from Project PRIORITY
    Roy, U. Basu
    Jacobson, M.
    Feldman, J.
    Elkins, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S156 - S156
  • [45] Exercising medical judgement: resuscitation and "Decision-Making for End-of-Life Care," a new policy from the College of Physician and Surgeons of Ontario
    Ajzenberg, Henry
    Connolly, Eoin
    Morrison, Kathryn
    Oczkowski, Simon
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2024, 71 (04): : 447 - 452
  • [46] Lessons learned from COVID-19 modelling efforts for policy decision-making in lower- and middle-income countries
    Owek, Collins J.
    Guleid, Fatuma Hassan
    Maluni, Justinah
    Jepkosgei, Joyline
    Were, Vincent O.
    Sim, So Yoon
    Hutubessy, Raymond Cw
    Hagedorn, Brittany L.
    Nzinga, Jacinta
    Oliwa, Jacquie
    BMJ GLOBAL HEALTH, 2024, 9 (11):
  • [47] Assessing public "participation" in environmental decision-making: Lessons learned from the UK Marine Conservation Zone (MCZ) site selection process
    De Santo, Elizabeth M.
    MARINE POLICY, 2016, 64 : 91 - 101
  • [48] Lessons Learned From Developing Dashboards to Support Decision-Making for Community Opioid Response by Community Stakeholders:Mixed Methods and Multisite Study
    Fareed, Naleef
    Olvera, Ramona G.
    Wang, Yiting
    Hayes, Michael
    Larimore, Elizabeth Liz
    Balvanz, Peter
    Langley, Ronald
    Noel, Corinna A.
    Rock, Peter
    Redmond, Daniel
    Neufeld, Jessica
    Kosakowski, Sarah
    Harris, Daniel
    Larochelle, Marc
    Huerta, Timothy R.
    Glasgow, Lashawn
    Oga, Emmanuel
    Villani, Jennifer
    Wu, Elwin
    JMIR HUMAN FACTORS, 2024, 11
  • [49] Implementing Shared Decision-Making in Oncology: Lessons From Taiwan's Experience for the Philippine Health-Care System
    Chen, Li-Hua
    Wei, Lien-Chung
    Chiu, Hsien-Jane
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2025,
  • [50] 'So Let's Go On Like This?'-Shared Decision-Making and the Use of Outcome Information in Routine Care Management for People With Multiple Sclerosis
    Damman, Olga C.
    Murugesu, Laxsini
    de Groot, Vincent
    de Jong, Brigit A.
    HEALTH EXPECTATIONS, 2024, 27 (05)